⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 15, 2024Pharmacogenetics and Genomics

Interaction of age and CYP2C19 genotypes on voriconazole steady-state trough concentration in Chinese patients

Yin‐Xiao Du Ying-Xia Zhu Liang Li Jing Yang Xiao‐Ping Chen

View Full Paper

Ask AI

Bookmark

Share

Abstract

Both age and CYP2C19 genotypes affect voriconazole plasma concentration; the interaction of age and CYP2C19 genotypes on voriconazole plasma concentration remains unknown. This study aims to investigate the combined effects of age and CYP2C19 genotypes on voriconazole plasma concentration in Chinese patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Du et al. (2024) studied this question.

synapsesocial.com/papers/68e6a13db6db643587624b19 https://doi.org/10.1097/fpc.0000000000000536

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Pharmacogenomic Profiling of Voriconazole Enables Predicting Its Toxicity in Pediatric Leukemia and Hematopoietic Stem Cell Transplant Recipients—A Prospective Study From North IndiaCohort Study · 2026
2Impact of CYP2C19, CYP2C9, CYP3A4, and FMO3 Genetic Polymorphisms and Sex on the Pharmacokinetics of Voriconazole after Single and Multiple Doses in Healthy Chinese Subjects2024 · 7 citations
3Discordant CYP2C19 genotype-phenotype relationship in voriconazole metabolism: impact of inflammation on drug exposure in a Chinese patientOriginal Research · 2026
4Influence of C-reactive protein on the pharmacokinetics of voriconazole in relation to the CYP2C19 genotype: a population pharmacokinetics analysis2024 · 15 citations
5Inflammation altered correlation between <i>CYP2C19</i> genotype and <scp>CYP2C19</scp> activity in patients receiving voriconazole2024 · 16 citations